↓ Skip to main content

RBM20, a potential target for treatment of cardiomyopathy via titin isoform switching

Overview of attention for article published in Biophysical Reviews, June 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
1 X user
patent
3 patents

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
54 Mendeley
Title
RBM20, a potential target for treatment of cardiomyopathy via titin isoform switching
Published in
Biophysical Reviews, June 2017
DOI 10.1007/s12551-017-0267-5
Pubmed ID
Authors

Wei Guo, Mingming Sun

Abstract

Cardiomyopathy, also known as heart muscle disease, is an unfavorable condition leading to alterations in myocardial contraction and/or impaired ability of ventricular filling. The onset and development of cardiomyopathy have not currently been well defined. Titin is a giant multifunctional sarcomeric filament protein that provides passive stiffness to cardiomyocytes and has been implicated to play an important role in the origin and development of cardiomyopathy and heart failure. Titin-based passive stiffness can be mainly adjusted by isoform switching and post-translational modifications in the spring regions. Recently, genetic mutations of TTN have been identified that can also contribute to variable passive stiffness, though the detailed mechanisms remain unclear. In this review, we will discuss titin isoform switching as it relates to alternative splicing during development stages and differences between species and muscle types. We provide an update on the regulatory mechanisms of TTN splicing controlled by RBM20 and cover the roles of TTN splicing in adjusting the diastolic stiffness and systolic compliance of the healthy and the failing heart. Finally, this review attempts to provide future directions for RBM20 as a potential target for pharmacological intervention in cardiomyopathy and heart failure.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 35%
Student > Ph. D. Student 8 15%
Other 7 13%
Student > Bachelor 4 7%
Student > Doctoral Student 2 4%
Other 6 11%
Unknown 8 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 24%
Medicine and Dentistry 10 19%
Agricultural and Biological Sciences 8 15%
Chemistry 5 9%
Social Sciences 2 4%
Other 4 7%
Unknown 12 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2022.
All research outputs
#4,750,811
of 23,706,541 outputs
Outputs from Biophysical Reviews
#90
of 829 outputs
Outputs of similar age
#81,858
of 318,591 outputs
Outputs of similar age from Biophysical Reviews
#2
of 10 outputs
Altmetric has tracked 23,706,541 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 829 research outputs from this source. They receive a mean Attention Score of 2.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,591 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.